Combined use of cholestanol derivative

Details for Australian Patent Application No. 2009220699 (hide)

Owner Otsuka Pharmaceutical Co., Ltd. National University Corporation Gunma University

Inventors Nishimura, Toyo; Yazawa, Shin; Asao, Takayuki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009220699

PCT Pub. Number WO2009/110235

Priority 2008-055284 05.03.08 JP

Filing date 4 March 2009

Wipo publication date 11 September 2009

International Classifications

A61K 31/704 (2006.01)

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/7072 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/110235 Priority application(s): WO2009/110235

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220707-Method for adjusting voice converting processor

2009220682-Method of denaturing whey protein